Nik Cremo

Stock Analyst at Barclays

(0.94)
# 4,023
Out of 5,118 analysts
125
Total ratings
42.4%
Success rate
-2.7%
Average return

Stocks Rated by Nik Cremo

Affirm Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $105 → $100
Current: $68.11
Upside: +46.82%
Chime Financial
Nov 5, 2026
Reiterated: Buy
Price Target: $40
Current: $31.33
Upside: +27.67%
Fidelity National Information Services
Nov 5, 2026
Reiterated: Hold
Price Target: $38 → $30
Current: $28.73
Upside: +4.42%
Jack Henry & Associates
Nov 5, 2026
Reiterated: Buy
Price Target: $185 → $190
Current: $173.23
Upside: +9.68%
The Western Union Company
Nov 5, 2026
Reiterated: Sell
Price Target: $6
Current: $6.88
Upside: -12.79%
Block
Nov 5, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $85.48
Upside: +22.84%
Fiserv
Nov 4, 2026
Reiterated: Hold
Price Target: $50 → $59
Current: $62.88
Upside: -6.17%
Toast
Nov 4, 2026
Reiterated: Buy
Price Target: $39
Current: $34.67
Upside: +12.49%
Strategy
Nov 2, 2026
Reiterated: Buy
Price Target: $175
Current: $128.93
Upside: +35.73%
Mastercard
Oct 30, 2026
Reiterated: Buy
Price Target: $660 → $700
Current: $652.70
Upside: +7.25%
Downgraded: Sell
Price Target: $56 → $53
Current: $59.24
Upside: -10.53%
Reiterated: Buy
Price Target: $420 → $440
Current: $422.65
Upside: +4.11%
Reiterated: Buy
Price Target: $15 → $17
Current: $6.02
Upside: +182.63%
Reiterated: Hold
Price Target: ILA 21,506
Current: ILA 15,040
Upside: +42.99%
Reiterated: Hold
Price Target: $20 → $16
Current: $13.60
Upside: +17.65%
Reiterated: Hold
Price Target: $81 → $89
Current: $97.40
Upside: -8.62%
Reiterated: Hold
Price Target: $172 → $165
Current: $182.22
Upside: -9.45%
Reiterated: Hold
Price Target: $340 → $315
Current: $455.16
Upside: n/a
Reiterated: Buy
Price Target: $34 → $39
Current: $22.67
Upside: n/a
Reiterated: Hold
Price Target: $14 → $27
Current: $17.50
Upside: n/a
Reiterated: Buy
Price Target: $32 → $30
Current: $2.19
Upside: n/a
Reiterated: Buy
Price Target: $160 → $130
Current: $52.41
Upside: n/a
Reiterated: Buy
Price Target: $24
Current: $4.40
Upside: n/a